0001437749-23-012180.txt : 20230502
0001437749-23-012180.hdr.sgml : 20230502
20230502214536
ACCESSION NUMBER: 0001437749-23-012180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230429
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danahy Kevin Patrick
CENTRAL INDEX KEY: 0001913245
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 23881437
MAIL ADDRESS:
STREET 1: 50 TEABERRY LANE
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-04-29
0001625101
Pulse Biosciences, Inc.
PLSE
0001913245
Danahy Kevin Patrick
C/O PULSE BIOSCIENCES, INC.
3957 POINT EDEN WAY
HAYWARD
CA
94545
1
Chief Executive Officer
0
Stock Option (right to buy)
6.44
2023-04-29
4
A
0
500000
A
2033-04-29
Common Stock
500000
500000
D
The option was granted on April 29, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to four tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.
Not applicable.
/s/ Kenneth B. Stratton, as Attorney-in-Fact
2023-05-02